Page last updated: 2024-11-05

trimetrexate and Dermatitis Exfoliativa

trimetrexate has been researched along with Dermatitis Exfoliativa in 1 studies

Trimetrexate: A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against PNEUMOCYSTIS PNEUMONIA in AIDS patients. Myelosuppression is its dose-limiting toxic effect.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weiss, RB1
James, WD1
Major, WB1
Porter, MB1
Allegra, CJ1
Curt, GA1

Other Studies

1 other study available for trimetrexate and Dermatitis Exfoliativa

ArticleYear
Skin reactions induced by trimetrexate, an analog of methotrexate.
    Investigational new drugs, 1986, Volume: 4, Issue:2

    Topics: Cellulitis; Dermatitis, Exfoliative; Humans; Quinazolines; Skin Diseases; Trimetrexate

1986